Ballicules.com

Latanoprost

XALATAN

What it isProstaglandin analog that increases uveoscleral outflow; first-line treatment for open-angle glaucoma.

Why this oneGeneric and potent with less hyperemia than bimatoprost, it is the default first prostaglandin drop.

What limits itIris and periocular darkening can be permanent; eyelash growth and orbital fat loss alter appearance. Adherence often determines failure.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Elevated IOP (open-angle glaucoma / ocular hypertension)Adults1 drop affected eye(s) QHS (evening)1 drop QD (evening)Once daily

Renal Undefined

Hepatic Undefined

Exceeding once-daily dosing may reduce IOP-lowering effect or paradoxically raise IOP

Instructions

Cautions

Adverse reactions

Pregnancy No adequate studies; animal data show malformations and embryofetal lethality at clinically relevant doses

Lactation Undefined

NO BOXED WARNINGS

Principal riskPermanent iris darkening and eyelash changes

Cost, est. cash$10–$400/month

Generic entry2011

Classes and tags

Clinical profile

Therapeutic safety burden0 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.

Active metabolites

Mechanism of action: Latanoprost ballicule

Latanoprost ballicule: receptor binding, kinetics and half-life diagram

Open Latanoprost in the interactive console ↗

Memory aids: mascots and interaction avatars

Latanoprost XALATAN mascot mnemonic cartoon
“X-tra Latin prost drops”
May cause iris darkening
May cause eyelash growth
Latanoprost Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Latanoprost in the interactive console ↗